Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 6/20 | 0.65 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | PNP | P00491 | 3/20 | 0.53 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.52 |
| ▸ | TK1 | P04183 | 1/20 | 0.47 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EDNRA | P25101 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9877452 | 1.00 | AHCY (0.65) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL9078539 | 1.00 | AHCY (0.65) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL10767171 | 1.00 | AHCY (0.65) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL29325364 | 1.00 | AHCY (0.65) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL1713028 | 1.00 | AHCY (0.65) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL10767166 | 1.00 | AHCY (0.65) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL9367067 | 0.97 | AHCY (0.60) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL10516308 | 0.97 | AHCY (0.60) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL10516867 | 0.97 | AHCY (0.60) | AHCYADORA2BADORA3PNPHPRT1 | |
| SCHEMBL9020125 | 0.97 | AHCY (0.60) | AHCYADORA2BADORA3PNPHPRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238323-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | EMORY UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238323-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | MTAP, PNP, SARS1 | AHCY 804/4885ADORA2B 322/4885ADORA3 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.